Charles Patti is one of the Co-Founders of Eleusis, a luxury psychedelic immersion center located on the Caribbean isle of St. Vincent and The Grenadines.

We learn about the extended state DMT protocol which is actively being administered to guests at the beachfront luxury clinic thanks to a government license, as well as the broader vision guiding the work at Eleusis.

This episode is brought to you by Full Canopy Genetics and by Mycogenius

Hosted on Acast. See acast.com/privacy for more information.

Travis Tyler Fluck was instrumental in laying the groundwork for the passage of decriminalization of entheogenic fungi in Denver, and he's been deeply involved in the community there for the arc of Prop 122 and the Natural Medicine Health Act. Today he returns to the Mycopreneur Podcast to share about his upcoming appearance at the Aspen Psychedelic Symposium where he'll be gifting 400 therapeutic level doses of psilocybin mushrooms away to attendees for free. The total cost of inputs and production of the 400 doses costs Travis was able to produce each dose for .43 cents each, totaling less than one person undergoing one licensed and legal psilocybin mushroom therapy session under the state-regulated framework.

This episode is brought to you by Full Canopy Genetics

This episode is also brought to you by Mycogenius

Hosted on Acast. See acast.com/privacy for more information.

Seth Colchester is the Founder of Mycogenius, a Netherlands-based manufacturer of premium functional mushroom extracts that are third-party tested and fully traceable. He is also the founder of Functionalmushrooms.eu, a wholesale provider of premium functional mushroom extracts and white labeling service for international brands.

Seth joins me today to discuss the mushroom industry in the EU in regards to culture, regulations, and market opportunity as it currently stands.

Please rate and review this podcast on whichever platform you're listening you're listening ( :

Hosted on Acast. See acast.com/privacy for more information.